Samuel Whiting - Jan 3, 2023 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Stephen Brady, Attorney-in-Fact for Samuel Whiting
Stock symbol
TPST
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 07:02 PM
Previous filing
Jun 22, 2022
Next filing
Oct 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +69.7K $0.00 69.7K Jan 3, 2023 Common Stock 69.7K $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service.